NCT05709197

Brief Summary

The goal of this clinical trial (REMBRANDT) is to evaluate the effectiveness of adding an extra connection (i.e. 'Braun anastomosis') after standard reconstruction in pancreatic head resection in reducing the incidence of delayed gastric emptying.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
256

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2023

Typical duration for not_applicable

Geographic Reach
1 country

12 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 24, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 2, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

April 17, 2023

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
Last Updated

April 11, 2024

Status Verified

April 1, 2024

Enrollment Period

2.4 years

First QC Date

January 24, 2023

Last Update Submit

April 10, 2024

Conditions

Keywords

Randomized controlled trialProspective studiesBraun anastomosisBraun enteroenterostomy

Outcome Measures

Primary Outcomes (1)

  • Delayed gastric emptying (DGE)

    DGE is defined by the need for maintenance of the nasogastric tube (NGT), need for reinsertion of NGT for persistent vomiting after postoperative day (POD) 7, or inability to tolerate a solid diet.

    During hospitalization

Secondary Outcomes (10)

  • Pancreatic fistula (POPF)

    During hospitalization

  • Anastomotic leak

    During hospitalization

  • Postoperative complications: incidence and severity

    During hospitalization

  • Number of days participants were hospitalized

    During hospitalization

  • Number of participants with in-hospital mortality

    During hospitalization

  • +5 more secondary outcomes

Study Arms (2)

Braun anastomosis

EXPERIMENTAL

Open pancreatoduodenectomy with Braun enteroenterostomy

Procedure: Braun anastomosis

Standard Child reconstruction

OTHER

Open pancreatoduodenectomy only

Procedure: Standard Child reconstruction

Interventions

Participants will undergo open pancreatoduodenectomy (PD). The reconstruction technique will not be standardized. In addition to the reconstruction technique used, a side-to-side anastomosis will be created between the afferent and efferent jejunal limbs of the gastrojejunostomy (GJ) at 20 cm distance from the GJ. The anastomosis will be hand-sewn with monofilament PDS 3-0 one-layer running suture.

Braun anastomosis

Participants will undergo open pancreatoduodenectomy (PD). The reconstruction technique will not be standardized. The surgeon is able to perform the PD as normally would be done (antecolic, retrocolic, pylorus-preserving or with distal gastric resecting).

Standard Child reconstruction

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Undergoing open pancreatoduodenectomy
  • Provided informed consent
  • Age over 18 years

You may not qualify if:

  • Insufficient control of the Dutch language to read the patient information and to fill out the questionnaires in Dutch hospitals
  • Previous bariatric surgery (such as Roux-en-Y gastric bypass, gastric sleeve)
  • Pregnancy
  • Bowel motility disorders
  • Minimally invasive pancreatoduodenectomy
  • Gastric outlet syndrome

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (12)

Amsterdam UMC

Amsterdam, Netherlands

NOT YET RECRUITING

OLVG

Amsterdam, Netherlands

NOT YET RECRUITING

Catharina hospital

Eindhoven, Netherlands

NOT YET RECRUITING

Medical spectrum Twente

Enschede, Netherlands

NOT YET RECRUITING

Groningen UMC

Groningen, Netherlands

NOT YET RECRUITING

Medical center Leeuwarden

Leeuwarden, Netherlands

NOT YET RECRUITING

LUMC

Leiden, Netherlands

NOT YET RECRUITING

Maastricht UMC+

Maastricht, Netherlands

NOT YET RECRUITING

St Antonius hospital

Nieuwegein, Netherlands

NOT YET RECRUITING

Radboud UMC

Nijmegen, Netherlands

RECRUITING

Erasmus MC

Rotterdam, Netherlands

NOT YET RECRUITING

Isala hospital

Zwolle, Netherlands

NOT YET RECRUITING

Related Publications (1)

  • Strijbos BTM, Hopstaken JS, Endo C, de Vries M, Atsma F, Adang E, van der Wees P, Besselink MGH, van Santvoort H, den Dulk M, Groot Koerkamp B, Mieog JSD, Zeverijn S, van Laarhoven CJHM, Stommel MWJ; Dutch Pancreatic Cancer Group. The effectiveness of adding Braun anastomosis to standard Child reconstruction to reduce delayed gastric emptying after pancreatoduodenectomy (REMBRANDT): study protocol for a multicentre randomised-controlled trial. Trials. 2025 Oct 2;26(1):387. doi: 10.1186/s13063-025-09051-x.

MeSH Terms

Conditions

Pancreatic DiseasesPancreatic NeoplasmsGastroparesis

Condition Hierarchy (Ancestors)

Digestive System DiseasesDigestive System NeoplasmsNeoplasms by SiteNeoplasmsEndocrine Gland NeoplasmsEndocrine System DiseasesStomach DiseasesGastrointestinal DiseasesParalysisNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Martijn WJ Stommel, MD, PhD

    Radboud University Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Patients will be blinded considering their treatment allocation. The house officer, ward nurses and data managers who extract data concerning the primary and secondary endpoint will be blinded for the allocation as well. For this reason, this will be a patient- and observer blinded RCT.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 24, 2023

First Posted

February 2, 2023

Study Start

April 17, 2023

Primary Completion

September 1, 2025

Study Completion

September 1, 2025

Last Updated

April 11, 2024

Record last verified: 2024-04

Locations